Adoptive cellular therapy in AML: challenges and different approaches

Key challenges in immunotherapy for AMLПодробнее

How can we improve efficacy of CAR T-cell therapy in AML?Подробнее

Addressing the major challenges to CAR-T therapy in AMLПодробнее

Challenges with CAR-T therapy in AML & insights into IF-BETTER-gated CAR-T cellsПодробнее

Challenges With CAR T-Cell Therapies in AMLПодробнее

An update on CAR-T therapy in AML: challenges & emerging strategiesПодробнее

How can CRISPR be used for adoptive T-cell therapy in AML?Подробнее

Improving Methods for Adoptive Cell Therapy ScreeningПодробнее

Challenges to Overcome With CAR T-Cell Therapy for Acute Myeloid LeukemiaПодробнее

Challenges of NK cell therapy in solid tumorsПодробнее

Examining the Current Role of CAR T-Cell Therapy in Acute Myeloid LeukemiaПодробнее

Potential for CAR T-Cell Therapy for R/R AMLПодробнее

AML Research Based on Different Amplicon Resequencing StrategiesПодробнее

Hurdles to CAR-T therapy for MDS & AML: T-cell fitness & lack of a uniform target antigenПодробнее

Adoptive T-cell Therapy: The Next Generation - Cassian Yee, M.D.Подробнее

The current role of immuno-oncology in AML and future outlooksПодробнее

CAR-T in solid tumors: challenges and future directionsПодробнее

Advancing the management of MDS and AML: Novel immune-based approachesПодробнее

The challenges in treating AML with CAR T-cell therapyПодробнее